Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer

অনুরূপ উপাদানগুলি

• Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
  অনুযায়ী: Foy, Susan P, অন্যান্য
  প্রকাশিত: (2013)
• Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells
  অনুযায়ী: Foy, Susan P., অন্যান্য
  প্রকাশিত: (2016)
• Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
  অনুযায়ী: Foy, Susan P., অন্যান্য
  প্রকাশিত: (2016)
• Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy
  অনুযায়ী: Mandl, Stefanie J, অন্যান্য
  প্রকাশিত: (2014)
• Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
  অনুযায়ী: Duan, Xiaopin, অন্যান্য
  প্রকাশিত: (2019)